News

At Formnext, Lithoz launches the CeraFab System S320 - an LCM printer with fivefold enlarged build platform

MADX receives coveted IVDR approval for its cutting-edge molecular allergy test

HOOKIPA Pharma to Present Strong Preclinical HB-700 Dataset

Marinomed Biotech AG reports positive clinical results for unique Carragelose eye drops

PIUR IMAGING Receives FDA Clearance for Revolutionary 3D Ultrasound Technology, PIUR tUS Infinity, Now Available in the U.S.

Life Sciences Masterplan Salzburg: Bund und Land investieren 15 Millionen Euro für Lebenswissenschaften

Areterna and Biomay announce strategic partnership for mRNA manufacturing

OeAW and Boehringer Ingelheim Foundation establish new Institute for biomedical artificial intelligence in Vienna

Valneva Submits Label Extension Applications for its Chikungunya Vaccine, IXCHIQ®, to EMA and Health Canada

Winners of the ÖGMBT Life Scienes Awards Austria 2024

Industrie begrüßt neues Institut für künstliche Intelligenz in der Biomedizin

Meduni Wien: Bleeding risk underestimated in patients with cancer

F2G Announces $100 Million Financing to Advance Late-Stage Development and Commercialization of Novel Antifungal Drug Candidate Olorofim in the US

Nationales Referenzzentrum für postvirale Syndrome wird an der MedUni Wien eingerichtet

ÖVIH begrüßt kostenlose Influenza-Impfung

CEBINA and Charles River Laboratories announce strategic collaboration to accelerate cutting edge neuroscience research into innovative therapeutics in the DanubeNeuro program

PMU feiert 1000sten Humanmedizin-Abschluss

Universität Wien: An Unexpected Result: The Mammalian Inner Ear is a Striking Example of Convergent evolution

Pharmig: Wirksamkeit und Sicherheit gehen bei Arzneimitteln Hand in Hand

Valneva Announces the Success of its Private Placement Raising approximately €60 Million